Organization
WPD Pharmaceuticals
2 clinical trials
Clinical trial
A Multicenter, Open-Label Study of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line TherapyStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Phase 1, Multicenter, Open-label, Dose Escalation Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade GliomasStatus: Not yet recruiting, Estimated PCD: 2025-12-01